Skip to content
10-Q

Quarterly Report

NextCure, Inc. NXTC

0001558370-25-006111

← back to feed
Filed
May 1, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 28, 2025 28.05M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $21.83M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $27.73M
Current Liabilities Q1 2025 · Mar 31, 2025 $5.74M
Current Liabilities Q1 2025 · Dec 31, 2024 $9.57M
Total Liabilities Q1 2025 · Mar 31, 2025 $11.28M
Total Liabilities Q1 2025 · Dec 31, 2024 $15.39M
Current Assets Q1 2025 · Mar 31, 2025 $58.9M
Current Assets Q1 2025 · Dec 31, 2024 $71.81M
Total Assets Q1 2025 · Mar 31, 2025 $67.14M
Total Assets Q1 2025 · Dec 31, 2024 $80.86M
Shares Diluted Q1 2025 · Mar 31, 2024 27.9M sh
Capex Q1 2025 · Mar 31, 2024 $37K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$12.61M
Stockholders Equity Q1 2025 · Mar 31, 2024 $99.05M
Stockholders Equity Q1 2025 · Dec 31, 2023 $114.42M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.61
Eps Basic Q1 2025 · Mar 31, 2024 −$0.61
Sga Expense Q1 2025 · Mar 31, 2024 $4.36M
Rd Expense Q1 2025 · Mar 31, 2024 $11.4M
Net Income Q1 2025 · Mar 31, 2024 −$17.11M
Operating Income Q1 2025 · Mar 31, 2024 −$18.3M